基因饮食在婴儿性综合征中的有效性和安全性:一个元分析
CaoXue Zuo1, KangJie Xu2, Kun Ni3
1Department of Neurology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Clinical Research Center of Neurodevelopmental Disabilities in Children in Hubei Province, Wuhan, China.
Seizure
|September 4, 2025
概括
饮食有效地减少了婴儿综合征 (IESS) 的. 这种饮食还能改善脑电图和发育,
科学领域:
- 神经学
- 儿童神经学
- 饮食疗法
背景情况:
- 婴儿综合征 (IESS) 是一种严重的综合征.
- 在IESS中,耐药性很常见,因此需要使用替代治疗策略.
研究的目的:
- 系统地评估基因饮食 (KD) 治疗IESS的有效性和安全性.
- 综合IESS患者KD预后研究的证据.
主要方法:
- 对电子数据库进行了全面的元分析.
- 确定并分析了IESS的KD预后研究.
- 使用随机效应模型进行数据合成.
主要成果:
- 在3至12个月的儿童中,KD的幅降低了≥50%.
- 在3-12个月的患者中,观察到19- 21%的患者没有发作.
- 在EEG,运动,认知和语言发育方面有显著的改善 (P < 0. 01).
- 常见的不良反应包括胃肠道问题和内部环境障碍 (32%).
结论:
- 饮食是一种有效和安全的治疗药物耐药性IESS.
- KD在控制和发育结果方面提供了显著的好处.
- 由于证据不确定性和出版偏见,需要进一步进行高质量的研究.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
439
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
439
Epilepsy and Seizures: Overview
274
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
274
Antiepileptic Drugs: Potassium Channel Activators
272
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
272
Antiepileptic Drugs: GABAergic Pathway Potentiators
632
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
632
Antiepileptic Drugs: Sodium Channel Blockers
861
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
861
Antiepileptic Drugs: Glutamate Antagonists
509
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
509


